American Joint Committee on Cancer (AJCC) Clinical Classification Predicts Conjunctival Melanoma Outcomes

@article{Shields2012AmericanJC,
  title={American Joint Committee on Cancer (AJCC) Clinical Classification Predicts Conjunctival Melanoma Outcomes},
  author={Carol L. Shields and Swathi Kaliki and Saad A. Al-Dahmash and Sara E. Lally and Jerry A. Shields},
  journal={Ophthalmic Plastic and Reconstructive Surgery},
  year={2012},
  volume={28},
  pages={313–323}
}
Purpose: The aim of this study was to evaluate conjunctival melanoma outcomes based on American Joint Committee on Cancer classification. The study design constituted a nonrandomized interventional case series. Methods: This was a retrospective chart review comprising 343 participants, and the main outcome measures were melanoma local recurrence, lymph node metastasis, distant metastasis, and death. Results: On the basis of the American Joint Committee on Cancer classification (seventh edition… Expand
Conjunctival Melanoma: Outcomes based on the American Joint Committee on Cancer Clinical Classification (8th Edition) of 425 Patients at a Single Ocular Oncology Center.
TLDR
Based on the AJCC 8 edition of conjunctival melanoma, the 10-year risk per T category significantly increased for visual acuity loss of >3 lines, recurrence/new tumor, exenteration, locoregional and systemic melanomas-related metastasis, and melanoma-related death. Expand
American Joint Committee on Cancer classification of posterior uveal melanoma (tumor size category) predicts prognosis in 7731 patients.
TLDR
Based on the AJCC classification, increasing tumor category was associated with older age, larger tumor, and greater incidence of subretinal fluid, hemorrhage, and extraocular extension. Expand
American Joint Committee on Cancer Classification of Uveal Melanoma (Anatomic Stage) Predicts Prognosis in 7,731 Patients: The 2013 Zimmerman Lecture.
TLDR
The clinical features and prognosis of posterior uveal melanoma based on the American Joint Committee on Cancer (AJCC) (7th edition) tumor staging were analyzed, finding that the rate of metastasis/death was 3 times greater for stage II, 9 to 10 times greatest for stage III, and further great for stage IV. Expand
Prognosis of eyelid sebaceous gland carcinoma based on the tumor (T) category of the American Joint Committee on Cancer (AJCC) classification
TLDR
Primary tumor (T) category of the AJCC classification predicts the prognosis of patients with eyelid SGC and the risk of systemic metastasis and death increases with increasing tumor category. Expand
Re: "American Joint Committee on Cancer (AJCC) clinical classification predicts conjunctival melanoma outcomes".
TLDR
In reply to the letter to the editor regarding Shields CL, Markowitz JS, Belinsky I, et al, Conjunctival melanoma: outcomes based on tumor origin in 382 consecutive cases, here are some of the key findings. Expand
Reply re: "American Joint Committee on Cancer (AJCC) clinical classification predicts conjunctival melanoma outcomes".
TLDR
In reply to the letter to the editor regarding Shields CL, Markowitz JS, Belinsky I, et al, Conjunctival melanoma: outcomes based on tumor origin in 382 consecutive cases, here are some of the key findings. Expand
Conjunctival melanoma: Risk factors for recurrent or new tumor in 540 patients at a single ocular oncology center.
TLDR
The results suggest that earlier detection and the first surgery in conjunctival melanoma management are critical for prevention of recurrent or new tumor, and it is recommended that prompt referral to an experienced surgeon is recommended. Expand
Greater Tumor Thickness, Ulceration, and Positive Sentinel Lymph Node Are Associated With Worse Prognosis in Patients With Conjunctival Melanoma
TLDR
The significant association between a positive SLN and worse DSS highlights the importance of SLNB for prognosis in patients with conjunctival melanoma and selecting high-risk patients for adjuvant drug treatment. Expand
Conjunctival Tumors in 5002 Cases. Comparative Analysis of Benign Versus Malignant Counterparts. The 2016 James D. Allen Lecture.
TLDR
In an ocular oncology practice, conjunctival tumors are benign (52%), premalignant (18%), or malignant (30%). Expand
Prognostication in eye cancer: the latest tumor, node, metastasis classification and beyond
TLDR
The most accurate criterion for prognostication in uveal melanoma is, however, analysis of chromosomal alterations and gene expression; when such data are available, the TNM stage may be used for further stratification. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 23 REFERENCES
Conjunctival melanoma: outcomes based on tumor origin in 382 consecutive cases.
TLDR
Melanoma arising de novo carries a higher risk of melanoma-related metastasis and death compared with those cases arising from PAM or nevus, and factors predictive of death by multivariable analysis included tumor origin de noVO. Expand
Re: "American Joint Committee on Cancer (AJCC) clinical classification predicts conjunctival melanoma outcomes".
TLDR
In reply to the letter to the editor regarding Shields CL, Markowitz JS, Belinsky I, et al, Conjunctival melanoma: outcomes based on tumor origin in 382 consecutive cases, here are some of the key findings. Expand
Prognostic value of clinical and histopathological parameters in conjunctival melanomas: a retrospective study
TLDR
A retrospective analysis of clinical and histopathological data of 69 patients with histologically verified conjunctival melanoma addresses the failure of retrospective studies on conjunctiva to prove the efficacy of a supplementary therapy to surgical excision. Expand
Conjunctival melanoma in the Netherlands: a nationwide study.
TLDR
Nonepibulbar tumors more often recur locally and are associated with a shorter survival independent of other risk factors, while tumor thickness is also an important predictor of regional and distant metastases, as well as survival. Expand
Patterns of regional and distant metastasis in patients with conjunctival melanoma: experience at a cancer center over four decades.
OBJECTIVE The regional lymph nodes generally are believed to be the most common first site of metastasis for conjunctival malignant melanoma, but the pattern of nodal metastasis in this disease hasExpand
Metastatic pattern and survival in disseminated conjunctival melanoma: implications for sentinel lymph node biopsy.
TLDR
Metastasis, especially initial regional lymph node metastasis, from limbal tumors and tumors less than 2 mm thick was rare, and these patients may have less benefit from sentinel lymph node biopsy, a method that is currently under evaluation regarding its potential to improve survival. Expand
Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.
  • C. Shields
  • Medicine
  • Transactions of the American Ophthalmological Society
  • 2000
TLDR
The technique of initial surgery was shown to be an important factor in preventing eventual tumor recurrence, metastasis, and death, and patients who were managed with excisional biopsy using the "no-touch technique" plus alcohol corneal epitheliectomy and supplemental cryotherapy fared far better than those treated with excisonalBiopsy alone. Expand
Primary acquired melanosis of the conjunctiva: risks for progression to melanoma in 311 eyes. The 2006 Lorenz E. Zimmerman lecture.
TLDR
Multivariable analysis revealed that the most significant factor for both PAM recurrence and progression to melanoma was extent of PAM in clock hours, whereas PAM with severe atypia shows progression to skin cancer in 13%. Expand
Population-based assessment of clinical characteristics predicting outcome of conjunctival melanoma in whites.
TLDR
The incidence of conjunctival melanoma in the white population of Finland increased analogous to cutaneous melanoma, and nonlimbal tumors recur more often and are associated with decreased survival, independent of their greater thickness. Expand
Conjunctival melanoma and melanosis: a reappraisal of terminology, classification and staging
TLDR
The TNM staging system for conjunctival melanoma should be revised to include a Tis stage, take account of tumour size, quadrant and caruncular involvement, and improve staging of any local invasion beyond conjunctiva. Expand
...
1
2
3
...